Survival Disparities Between Children and Adolescents and Young Adults for the Major Subtypes of Non-Hodgkin Lymphoma in the Netherlands: a Large Population-based Study
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
What can we learn from cancer registries?.
Burkhardt B Haematologica. 2023; 109(3):716-717.
PMID: 37916385 PMC: 10905063. DOI: 10.3324/haematol.2023.284104.
References
1.
Minard-Colin V, Auperin A, Pillon M, Burke G, Barkauskas D, Wheatley K
. Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children. N Engl J Med. 2020; 382(23):2207-2219.
PMC: 7720281.
DOI: 10.1056/NEJMoa1915315.
View
2.
Alvarez E, Le T, Kahn J, Winestone L, Li Q, Keegan T
. Comorbidities and socioeconomic status are predictors of survival in children and young adults with Burkitt lymphoma. Leuk Lymphoma. 2021; 62(11):2804-2807.
DOI: 10.1080/10428194.2021.1932873.
View
3.
Sandlund J, Martin M
. Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum. Hematology Am Soc Hematol Educ Program. 2016; 2016(1):589-597.
PMC: 6142492.
DOI: 10.1182/asheducation-2016.1.589.
View
4.
Abrahao R, Ribeiro R, Lichtensztajn D, Rosenberg A, Keegan T
. Survival after diffuse large B-cell lymphoma among children, adolescents, and young adults in California, 2001-2014: A population-based study. Pediatr Blood Cancer. 2018; 66(4):e27559.
PMC: 9423938.
DOI: 10.1002/pbc.27559.
View
5.
Cairo M, Beishuizen A
. Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives. Br J Haematol. 2019; 185(6):1021-1042.
PMC: 6897376.
DOI: 10.1111/bjh.15764.
View